Protection against mpox appears stronger and more durable from a previous infection than with vaccination (MVA-BN), suggesting the need to research whether booster vaccination can enhance immunologic memory.
Researchers conducted a combined prospective and retrospective cohort study at the Institute of Tropical Medicine in Belgium. They evaluated long-term mpox sequelae, viral persistence in body fluids, and comparative antibody dynamics between prior mpox infection and MVA-BN vaccination.
Read the full news story here.
/Infectious Disease Advisor requires free registration if more than 5 articles are viewed per month/
Source : Infectious Disease Advisor
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.